MASLD is a common liver condition driven by metabolic dysfunction. Losing 10% of body weight can reverse liver damage, and GLP-1 drugs like semaglutide help by reducing fat, inflammation, and improving insulin sensitivity. Combined with lifestyle changes, they offer real hope.
View More